BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guo A, Li K, Xiao Q. Sarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets? Exp Gerontol 2020;139:111022. [PMID: 32707318 DOI: 10.1016/j.exger.2020.111022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Guo A, Li K, Tian HC, Tao BL, Xiao Q, Jiang DM. FGF19 protects against obesity-induced bone loss by promoting osteogenic differentiation. Biomed Pharmacother 2021;146:112524. [PMID: 34906775 DOI: 10.1016/j.biopha.2021.112524] [Reference Citation Analysis]
2 Jo D, Yoon G, Kim OY, Song J. A new paradigm in sarcopenia: Cognitive impairment caused by imbalanced myokine secretion and vascular dysfunction. Biomedicine & Pharmacotherapy 2022;147:112636. [DOI: 10.1016/j.biopha.2022.112636] [Reference Citation Analysis]
3 Mengeste AM, Rustan AC, Lund J. Skeletal muscle energy metabolism in obesity. Obesity (Silver Spring) 2021;29:1582-95. [PMID: 34464025 DOI: 10.1002/oby.23227] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Scisciola L, Fontanella RA, Surina, Cataldo V, Paolisso G, Barbieri M. Sarcopenia and Cognitive Function: Role of Myokines in Muscle Brain Cross-Talk. Life (Basel) 2021;11:173. [PMID: 33672427 DOI: 10.3390/life11020173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]